Hepatocellular carcinoma

Citation
Df. Schafer et Mf. Sorrell, Hepatocellular carcinoma, LANCET, 353(9160), 1999, pp. 1253-1257
Citations number
63
Categorie Soggetti
General & Internal Medicine","Medical Research General Topics
Journal title
LANCET
ISSN journal
01406736 → ACNP
Volume
353
Issue
9160
Year of publication
1999
Pages
1253 - 1257
Database
ISI
SICI code
0140-6736(19990410)353:9160<1253:HC>2.0.ZU;2-J
Abstract
Hepatocellular carcinoma (HCC) for most patients is a terminal complication of chronic inflammatory and fibrotic liver disease. With regrettably few e xceptions, treatment is largely palliative, and long-term survival Is rare. However, the major causes of HCC worldwide are known and preventable. Hepa titis B and C exist only in man; the viruses have no known non-human reserv oirs. Transmission of the viruses can be interrupted by vaccination against hepatitis B virus infection acid improvements in medical techniques for he patitis C; for which no vaccine has yet been developed.